Page last updated: 2024-10-31

nefopam and Cancer Pain

nefopam has been researched along with Cancer Pain in 1 studies

Nefopam: Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for the relief of acute and chronic pain. (From Martindale, The Extra Pharmacopoeia, 30th ed, p26)
nefopam : A racemate comprising equal amounts of (R)- and (S)-nefopam. The hydrochloride is a centrally acting non-opiate analgesic commonly used for the treatment of moderate to severe pain.
5-methyl-1-phenyl-3,4,5,6-tetrahydro-1H-2,5-benzoxazocine : A member of the class of benzoxazocines that is 3,4,5,6-tetrahydro-1H-2,5-benzoxazocine substituted by phenyl and methyl groups at positions 1 and 5 respectively.

Cancer Pain: Pain that may be caused by or related to cellular, tissue, and systemic changes that occur during NEOPLASM growth, tissue invasion, and METASTASIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Pasutharnchat, K1
Wichachai, W1
Buachai, R1

Trials

1 trial available for nefopam and Cancer Pain

ArticleYear
Analgesic efficacy of nefopam for cancer pain: a randomized controlled study.
    F1000Research, 2020, Volume: 9

    Topics: Adult; Aged; Analgesics, Non-Narcotic; Cancer Pain; Double-Blind Method; Female; Humans; Male; Middl

2020